Introduction {#s1}
============

Most biological processes within cells involve multiple genes ([@B46]; [@B62]). Inferring the regulatory relationships between genes is important for understanding the functional organization within cells and helps to reveal the mechanisms of complex diseases ([@B34]). In recent years, a large number of works have been proposed for inferring gene regulatory networks (GRNs) from gene expression data ([@B46]; [@B12]; [@B55]; [@B62]; [@B34]; [@B39], [@B40]). Despite their success in addressing some biological problems, revealing the comprehensive GRNs is still a challenging task ([@B62]; [@B19]).

Gaussian graphical model (GGM) is an attractive paradigm to depict the associations among biomolecules ([@B59]). In GGM, each node of the graph represents a random variable from a random vector subjected to multivariate normal distribution, and there is an edge between two nodes if the corresponding two random variables are conditionally dependent, which means the corresponding element of the precision matrix (or inverse covariance matrix) is non-zero ([@B13]; [@B54]). This property makes GGM so popular because we are able to get the network structure by just estimating the precision matrix ([@B59]). Unfortunately, in the analysis of gene expression data, the number of samples is usually far less than the dimension of a random vector, which makes it hard to estimate the precision matrix directly (the empirical covariance is not invertible). By assuming that the precision matrix is sparse and the data samples are drawn independently from the same distribution, several approaches have been proposed to estimate the precision matrix ([@B36]; [@B59]; [@B2]).

However, as biological systems are highly dynamic ([@B28]), we are faced with observations collected from different states ([@B25]). For example, the gene expression data can be collected from both the diseased and normal tissues ([@B51]; [@B39]). Thus, if we estimate each state-specific network separately for each sample set, the common structures within different state-specific networks will be ignored. In contrast, inferring a single network from all sample sets may mask their differences. To address this problem, many works have been proposed in recent years to jointly estimate multiple graphical models ([@B20]; [@B12]; [@B40]). When the focus is to infer the differential network between two different states, instead of inferring two state-specific networks, some works have also been developed to estimate the differential network directly ([@B61]; [@B58]).

Although the above methods for learning the structure of multiple GGMs have been successfully used to estimate the regulatory relationships among genes, their performance may be limited since they do not consider the existing knowledge about genes and their regulatory relationships. For example, a pathway is a set of components that interact with each other to perform specific biological tasks. Researches have found that many diseases arose from the joint action of multiple genes within a pathway ([@B43]). Therefore, pathway-based learning of gene regulatory networks may yield biological insights that are hard to detect by traditional GGMs ([@B19]). Although a pathway graphical lasso model has been proposed to incorporate pathway-based constraints into GGMs ([@B19]), it is designed for single network estimation and cannot jointly estimate multiple GGMs. Moreover, with the accumulation of high-throughput data, we are able to collect some literature-curated gene interactions from public database ([@B22]; [@B57]). As the state-specific gene regulatory relationships as well as their changes across multiple states are more likely to take place between genes that are known to have interactions, incorporating these prior information may help to identify the changes of GRNs more accurately ([@B57]).

To address the above problems, in this paper, we proposed a novel weighted fused pathway graphical lasso (WFPGL) to jointly estimate multiple gene networks as well as their difference by incorporating prior knowledge derived from known pathways and gene interactions. In particular, given a set of pathways, we first assume that regulatory relationships will not take place between genes that belong to different pathways. Here, the pathway information is assumed to be able to provide us prior knowledge that certain edges are unlikely to be present ([@B19]). Under this assumption, the incorrect links across pathways will be eliminated, as shown in [**Figure 1**](#f1){ref-type="fig"}. To make use of the prior knowledge from public gene interaction database and draw support from multiple sample sets collected from different states, we introduce a weighted fused lasso penalty in our model. The proposed WFPGL is optimized by alternating direction method of multipliers (ADMM) ([@B7]), and we follow the idea of pathway graphical lasso that decomposes the original problem into pathway-based subproblem to accelerate the optimization. To demonstrate the performance of our new algorithm, we first conduct simulation studies and compare our algorithm with other five state-of-the-art graphical models. Experiment results on synthetic data show that our WFPGL outperforms other related methods. We then apply our WFPGL on two real datasets. The first experiment is to estimate the gene regulatory networks of insulin sensitive and insulin resistant type 2 diabetes patients. Experiment results demonstrate that our method could identify some promising candidate genes related to insulin resistance. The second experiment is to jointly estimate the gene regulatory networks of four breast cancer subtypes. We find that our identified subtype-specific networks have some shared and specific structures, which may help to reveal the mechanisms of cancer differentiation. Overall, the experiment results on synthetic and real data demonstrate that our WFPGL could effectively utilize prior knowledge to jointly estimate multiple gene networks. The datasets and source codes of our proposed WFPGL are freely available at <https://github.com/NuosiWu/WFPGL>.

![Illustration of the proposed method. **(A)** Graphical lasso just uses gene expression data to separately estimate each state-specific network, leading to incorrect estimation results. **(B)** The proposed weighted fused pathway graphical lasso jointly estimates multiple state-specific networks by considering the prior knowledge of gene interaction networks and pathways, which could eliminate the spurious links between different pathways and results in more accurate estimation of the networks across multiple states.](fgene-10-00623-g001){#f1}

The rest of this paper is organized as follows. In the section Weighted Fused Pathway Graphic Lasso, we formulate our WFPGL and describe the optimization processes. In the section Simulation Studies, we illustrate the performance of WFPGL and another five state-of-the-art methods on synthetic datasets. The section Real Data Analysis provides studies on two real datasets, and the section Conclusion discusses the utilization of the method.

Weighted Fused Pathway Graphical Lasso {#s2}
======================================

Problem Formulation {#s2_1}
-------------------

Suppose *X* ^(1)^, ..., *X* ^(^ *^K^* ^)^ are *K* groups of sample sets that measure the gene expression levels of *p* genes across *K* different states. Each *X* ^(^ *^k^* ^)^ ∈ R*^p^* ^×^ *^n^~k~* may have a different sample size *n~k~*, and samples within each group (or state) are independent and follow same multivariate Gaussian distribution. Then maximizing the likelihood functions of multiple Gaussian graphical model is equivalent to solving the following optimization problem ([@B54]):
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where *S^(k)^* is the sample covariance matrix for *X* ^(^ *^k^* ^)^ and Θ^(^ *^k^* ^)^ is the inverse covariance matrix (or precision matrix).

To learn the parameters Θ^(^ *^k^* ^)^ (which represent networks) for *k* = *1, ..., K*, additional penalty is often required to guarantee structural recovery especially for high-dimensional setting. Fused lasso penalty, which imposes sparse penalties not only on individual networks but also on the differences between each pair of networks, has been proven to be effective on joint estimation of multiple networks ([@B12]). However, traditional fused lasso penalty does not take into account prior information. As the changes of GRNs across different states are more likely to take place between genes that are known to interact with each other ([@B57]), we encourage the identification of differential edges that appear in the known gene interaction network. Thus, given a prior gene interaction network with adjacency matrix *G*, we introduce the following weighted fused lasso penalty function:

F

(

{

Θ

(

k

)

}

)

=

λ

1

∑

k

=

1

K

∑

i

≠

j

W

i

j

\|

θ

i

j

(

k

)

\|

\+

λ

2

∑

k

\<

k

′

∑

i

,

j

W

i

j

\|

θ

i

j

(

k

)

−

θ

i

j

(

k

′

)

\|

.

Here, λ~1~ \> 0 is a tuning parameter controlling the sparsity of precision matrices, λ~2~ \> 0 is a tuning parameter controlling the sparsity of the differential networks, and *W~ij~* is the weight assigned to a pair of genes. In this study, the weight is set as follows:
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where *w* ∈ \[0, 1\] is a predefined parameter. The smaller the value of *w*, the more likely the corresponding edge will be identified.

As we could make use of pathway information to specify sets of genes that are more likely to work together, incorporating pathway information may help to improve the structure learning of GRNs and achieve more meaningful and interpretable results. Following the ideal of pathway graphical lasso ([@B19]), we constrain the graphical model so that the elements in precision matrices are fixed to 0 if the corresponding gene pairs are not together in any pathways.

Suppose there are *J* pathways within the *p* genes (denoted as *P~t~*, *t* = 1, ..., *J*), and considering the pathway constraints and the knowledge of prior gene interaction network, the objective function of our WFPGL model is as follows:
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where *F*({Θ^(^ *^k^* ^)^}) takes the form of function (2).

Optimization {#s2_2}
------------

### Pathway Separable {#s2_2_1}

Given *J* pathways, let $\Theta_{t}^{(k)}(t = 1,\ldots,J)$ denote a sub-matrix of Θ^(^ *^k^* ^)^, which models the sub-graph within the *p~t~* genes in *t*-th pathway (*p* ~1~ + ⋯ + *p~J~* = *p*). After some permutations of the rows and columns under the pathway constraints, Θ^(^ *^k^* ^)^ can be rearranged into the following form:
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where $\Theta_{1}^{(k)} = \left\lbrack \begin{array}{ll}
\Theta_{11}^{(k)} & \Theta_{12}^{(k)} \\
\Theta_{21}^{(k)} & \Theta_{22}^{(k)} \\
\end{array} \right\rbrack$ contains all edges in the first pathway, and $\Theta_{other}^{(k)} = \left\lbrack \begin{array}{ll}
\Theta_{22}^{(k)} & \Theta_{23}^{(k)} \\
\Theta_{32}^{(k)} & \Theta_{33}^{(k)} \\
\end{array} \right\rbrack$ contains the parameter in the rest of the pathways. $\Theta_{22}^{(k)}$ is the overlapping part of Θ~1~ and Θ~other~, which is a square matrix containing all links among the genes that co-occur in the pathways as well as the remaining pathways. Applying the Schur complement decomposition, we have

det

⁡

(

Θ

(

k

)

)

=

det

(

Θ

33

k

)

⋅

det

⁡

(

Θ

1

k

−

∆

1

(

k

)

)

,

where $\mathrm{\Delta}_{1}^{(k)} = \lbrack 0;\Theta_{23}^{k}\rbrack \cdot {(\Theta_{33}^{k})}^{- 1} \cdot \lbrack 0,\,\Theta_{32}^{(k)}\rbrack$. If we hold the parameters from other pathways fixed and just update the parameters in the first pathway, $\mathrm{\Delta}_{1}^{(k)}$ will be a constant matrix, and problem (1) boils down to maximizing the following function:
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where the matrix with subscript denotes the sub-matrix corresponding to the first pathway. Notice that (7) is exactly the likelihood function for updating $\Theta_{1}^{(k)} - \mathrm{\Delta}_{1}^{(k)}$, and $\mathrm{\Delta}_{1}^{(k)}$ is constant and can be pre-calculated. Updating $\Theta_{1}^{(k)}$ within a certain pathway *via* maximizing likelihood function only requires information from the corresponding pathway itself. We define a function with such property to be pathway separable.

### Optimization Work Flow {#s2_2_2}

Problem (4) is converted into the following equivalent problem:
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which can be solved with the ADMM method ([@B7]) by minimizing the following augmented Lagrangian function:
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where \<*A*, *B*\> = tr (*AB^T^*),‖*A*‖ denotes the Frobenius norm of matrix *A*, *μ* \> 0 is a penalty parameter, and *Y* ^(^ *^k^* ^)^ is a Lagrangian multiplier. We let *V* ^(^ *^k^* ^)^ = *Y* ^(^ *^k^* ^)^/*μ*, and (9) can be rewritten as the ultimate objective function:
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###### 

Framework of alternating direction method of multipliers (ADMM).

  --------------------------------------------------------------------------------------------------------------------------------------------
  **Input:** *S*, *n~k~*, *μ*, λ*~1~*, λ*~2~*\
  **Initializing:** *μ* = 1, $\Theta_{0}^{(k)} = I,V_{(0)}^{(k)} = 0,Z_{(0)}^{(k)} = 0,$\
  for *k* = 1, 2, ..., *K*.\
  1: **while** not converged **do**\
  2: $\{\Theta_{(i)}^{(k)}\}\overset{}{\leftarrow}arg\, min_{\Theta}L_{\mu}(\{\Theta^{(k)}\},\{ Z_{(i - 1)}^{(k)}\},\{ V_{i - 1}^{(k)}\}).$\
  3: $\{ Z_{(i)}^{(k)}\}\overset{}{\leftarrow}arg\, min_{\Theta}L_{\mu}(\{\Theta_{(i)}^{(k)}\},\{ Z^{(k)}\},\{ V_{i - 1}^{(k)}\}).$\
  4: $\{ V_{(i)}^{(k)}\}\overset{}{\leftarrow}\{ V_{(i)}^{(k)}\} + \{\Theta_{(i)}^{(k)}\} - \{ Z_{(i)}^{(k)}\}).$\
  5: *i* ← *i* + 1\
  6: **end while**

  --------------------------------------------------------------------------------------------------------------------------------------------

ADMM solves above problem by three steps in every iteration, as shown in Algorithm 1.

### ADMM Solver {#s2_2_3}

It is easy to verify that $\left| \middle| \Theta^{(k)} - Z^{(k)} + V^{(k)} \middle| |_{F}^{2} \right.$ is pathway separable. This allows us to use a block-coordinate descent approach for accelerating the updating of Θ^(^ *^k^* ^)^ ([@B52]; [@B19]). By updating $\Theta_{t}^{(k)}$ in each pathway individually while leaving the parameters in other pathway fixed, the complexity of the problem is narrowed down, and the pathway constraints on the precision matrix naturally meet since the parameters outside the pathway remain 0. Specifically, let $T_{t}^{(k)} = \Theta_{t}^{(k)} - \mathrm{\Delta}_{t}^{(k)}$, and we update $\Theta_{t}^{(k)}$ by solving the subproblem, as follows:
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Here, the subscript *t* of a matrix denotes the index of the sub-matrix that corresponds to the *t*-th pathway. [@B19] have introduced an efficient message passing algorithm to calculate $\mathrm{\Delta}_{t}^{(k)}$ efficiently. The solution to this problem is *UCU^T^*, where *UDU^T^* represents the eigendecomposition of $S_{t}^{(k)} + \mu/n_{k}(\mathrm{\Delta}_{t}^{(k)} - Z_{t}^{(k)} + V_{t}^{(k)})$, and *C* is a diagonal matrix with *i*-th diagonal element to be $\frac{n_{k}}{2\mu}\{ - D_{ii} + {(D_{ii}^{2} + 4\mu/n_{k})}^{1/2}\}$

The second step is to update *Z* ^(^ *^k^* ^)^ as the minimizer of
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The solution to this problem can be obtained by the method introduced in [@B23]. The last step for each iteration is to update V^(^ *^k^* ^)^ as V^(^ *^k^* ^)^ + Θ^(^ *^k^* ^)^ − *Z* ^(^ *^k^* ^)^. We stop the algorithm until ${\sum_{k}{||}}\Theta_{(i)}^{(k)} - \Theta_{(i - 1)}^{(k)}||_{F}^{2}\text{/}{\sum_{k}{||\Theta_{(i - 1)}^{(k)}}}||_{F}^{2} < 10^{- 5}$

Simulation Studies {#s3}
==================

We compare the performance of WFPGL with that of five state-of-the-art graphical models: 1) graphical lasso (GL) ([@B36]), which is a classical algorithm for precision matrix estimation; 2) pathway graphical lasso (PGL) ([@B19]), which is a framework that uses pathway knowledge to estimate single Gaussian graphical model; 3) fused graphical lasso (FGL) ([@B12]), which is a method for joint estimation of multiple precision matrices across multiple states; 4) differential network estimation *via* D-trace loss (Dtrace) ([@B58]), which is a method for direct estimation of a differential network between two states; and 5) weighted D-trace loss (WDtrace) ([@B57]), which is an algorithm proposed for inferring differential network rewiring by integrating static gene regulatory network information. We implement GL and FGL with their R packages and perform PGL and WFPGL in python environment and using Matlab to carry out Dtrace and WDtrace.

WFPGL has three tuning parameters, i.e., the sparsity controllers λ~1~ and λ~2~ and the weight of prior information *w*. For *w*, as suggested by [@B57], we set *w* = 0.3 in the following experiments.

To evaluate the performance of various, we adopt four evaluation metrics named true-positive rate (TPR), false-positive rate (FPR), true-positive differential rate (TPDR), and false-positive differential rate (FPDR). Let *θ~ij~* and ${\hat{\theta}}_{ij}$ denote the elements in true precision matrix and the estimated precision matrix, respectively. The definitions of these four metrics are as follows:
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According to the above definitions, TPR and FPR measure the accuracy of network estimation, whereas TPDR and FPDR measure the accuracy of differential network estimation.

Experiments on Two Groups of Samples {#s3_1}
------------------------------------

In this section, we first consider the situation when there are two groups of samples corresponding to two different states. The main generation procedure of the synthetic datasets is described as follows.

1.  STEP 1: PATHWAY DEFINITION

    For ease of simulation study, we simply put successive features into one pathway and let the intersection of two pathways to be non-empty set only when the pathways are "neighbors." We create 10 pathways with same size that covers all 400 features with *n* ~ol~ = 5 features overlapped in neighbor pathway. Let *P~t~* (*t* = 1, ..., 10) represent a pathway set in which the element indicates the index of feature. In such configuration, pathways are generated as *P* ~1~ = {1, 2, ..., 45}, *P* ~2~ = (41, 42, ..., 85}, ..., *P* ~10~ = (361, 362, ..., 400}.

2.  STEP 2: NETWORK CONSTRUCTION

    We first build a random scale-free network for the state 1, denoted by its adjacency binary matrix *M* ^(1)^. ${\widetilde{M}}^{(1)}$ is a copy of *M* ^(1)^ with each non-zero element substituted by a uniform distribution value on \[−0.6, −0.3\] ∪ \[0.3, 0.6\]. Then ${\widetilde{M}}^{(2)}$ is generated by the copy of ${\widetilde{M}}^{(1)}$, with about *r* = 30% non-zero elements vanished.

3.  STEP 3: PRIOR NETWORK GENERATION

    We select a proportion (ㅰ*η*) of edges from *M* ^(1)^ and connect the corresponding features in prior gene interaction network *G*.

4.  STEP 4: PRECISION MATRIX CALCULATION

    To ensure the positive definiteness of the covariance matrix, we get the real precision matrix ${\widetilde{\Theta}}^{(k)}$ as
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where ⚬ is Hadamard product operator, *Q* is a *p* × *p* binary "pathway network" matrix in which the "1" element indicates the corresponding feature pairs that co-occur in any of the pathways, σ is the absolute value of the minimum eigenvalues of $({\widetilde{M}}^{(k)} \circ Q)$ for *k* = 1, 2, and *I* is identity matrix.

After the precision matrix ${\widetilde{\Theta}}^{(k)}$ for each state is settled in Step 4, the synthetic gene expression data could be generated with zero means and $\Sigma = {\widetilde{\Theta}}^{- 1}$.

We generate 50 random two-state datasets with the same setting: *n~k~* = 100 samples for both two states, 10 pathways with an overlapping number *n* ~ol~ = 5 covering all *p* = 400 genes as introduced in Step 1.

As defined in Step 3 of dataset generation, prior rate *η* controls the proportion of true edges that is covered by prior gene interaction network. Note that the edges in the prior gene interaction network are not necessarily differential edges. We set *η* to be 0, 0.4, and 0.8 to see its impact on the performance of WFPGL.

[**Figure 2**](#f2){ref-type="fig"} presents the average performance of various methods over 50 random generations of data with different values of parameters. In particular, for GL, PGL, Dtrace, and WDtrace that have one sparsity-controlling parameter, we vary the value of the parameter and show their performance. For FGL and WFPGL that have two tuning parameters, i.e., λ~1~ and λ~2~, which control the sparsity of individual networks and their difference, respectively, we fix the value of λ~2~ and show their performance with the value of λ~1~ varied. The performance of different methods is shown in distinct colors. Dtrace and WDtrace do not have TPR and FPR, since these two methods directly estimate the differential network between two states and do not predict the individual networks. For GL, PGL, Dtrace, and WDtrace, each curve depicts the performance from a wide range of the sparsity-controlling parameter. For FGL and WFPGL, we pick up three curves here to show their performance. Each curve presents the results with λ~2~ being fixed to a certain value: solid line for λ~2~ = 0.0001, dashed line for λ~2~ = 0.001, and dotted line for λ~2~ = 0.01.

![The experiment results of various methods on two groups of samples, with the value of η changing at **(A)** η = 0, **(B)** η = 0.4, and **(C)** η = 0.8. The performance of various methods on individual network estimation \[with respect to true-positive rate (TPR) and false-positive rate (FPR)\] is shown on the left side, while the performance of various methods on differential network estimation \[with respect to true-positive differential rate (TPDR) and false-positive differential rate (FPDR)\] is shown on the right side. For weighted fused pathway graphical lasso (WFPGL) and fused graphical lasso (FGL), different line styles correspond to different choices of λ~2~: solid line for λ~2~ = 0.0001, dashed line for λ~2~ = 0.001, and dotted line for λ~2~ = 0.01.](fgene-10-00623-g002){#f2}

The plots on the left side of [**Figure 2**](#f2){ref-type="fig"} show the performance of various methods for individual network estimation. We can find that pathway-based methods WFPGL and PGL dominate other methods that do not use pathway information. Joint estimation methods outperform single network estimation methods (WFPGL performs better than PGL, and FGL performs better than GL). This may be because the joint estimation methods can draw support from multiple sample sets to achieve a more accurate estimation. Though λ~2~ controls the sparsity of differential networks, it also affects the accuracy of individual network estimation with larger values result in a better prediction.

The plots on the right side of [**Figure 2**](#f2){ref-type="fig"} show the results of differential network prediction. WFPGL also outperforms other methods, since it uses both two views of prior knowledge, followed by PGL that only uses pathway information and WDtrace that only uses prior gene interaction network knowledge. GL, FGL, and Dtrace, which do not use any prior knowledge, cannot identify differential networks accurately. There is a distinct improvement on the performance of WFPGL and WDtrace when the value of *η* increases, which indicates the effectiveness of using prior gene interactions.

To evaluate the performance of various methods without prior network information or prior pathway information, we show the results of various methods without prior network information (i.e., *η*= 0) in [**Figure 2**](#f2){ref-type="fig"}, and we show the results of various methods without prior pathway information in the [**Supplementary Material (Figure S1)**](#SM1){ref-type="supplementary-material"}. In fact, when there is no prior network information, our method degenerates to a fused pathway graphical lasso model. When there is no prior pathway information, our method degenerates to a weighted fused graphical lasso model. We can find from [**Figure 2**](#f2){ref-type="fig"} and [**Figure S1**](#SM1){ref-type="supplementary-material"} that when there is no prior network or prior pathway information, our method could still achieve competitive performance with other comparative methods.

Experiments on Three and Four Groups of Samples {#s3_2}
-----------------------------------------------

We generate three groups of samples (corresponding to three different states) with *p* = 400 features and *n* = 50 samples per group, and we assume that there are eight pathways covering all features with the overlapping *n~ol~* = 10. The first two networks are generated in the same way as the above section, except that only *r* = 10% edges are deleted from state 1 to form the network of state 2 (Step 2). The precision matrix for state 3 is copied from state 2, with the removed elements in state 2 being reassigned by uniform distributed values \[−0.6, −0.3\] ∪ \[0.3, 0.6\] with the possibility of 0.5.

To further test the robustness of WFPGL, we generated a dataset with four different states. In particular, we generated four groups of samples with *p* = 200 features and *n* = 50 samples per group, covered by five pathways with *n~ov~* = 8. The first three networks are generated the same way as the above section except that the different rate is set to be *r* = 20%. Then we randomly deleted 20% non-zero elements from state 1 to build the network of state 4.

Similarly, 50 random datasets are generated for the above two situations, and [**Figure 3**](#f3){ref-type="fig"} shows the averaged results with *η* = 0.8. Because Dtrace and WDtrace cannot handle the estimation of multiple differential networks, we compare WFPGL with GL, PGL, and FGL. WFPGL still outperforms others on both individual and differential network estimations, followed by PGL, which uses pathway information only. FGL and GL do not perform well on these datasets, though FGL performs slightly better than GL on individual network estimation.

![The experiment results of various methods on multiple groups of samples: **(A)** Dataset 1 for three states. **(B)** Dataset 2 for four states. The performance of various methods on individual network estimation (with respect to TPR and FPR) is shown on the left side, while the performance of various methods on differential network estimation (with respect to TPDR and FPDR) is shown on the right side. For WFPGL and FGL, different line styles corresponding to different choices of λ~2~: solid line for λ~2~ = 0.0001, dashed line for λ~2~ = 0.001, and dotted line for λ~2~ = 0.01.](fgene-10-00623-g003){#f3}

Real Data Analysis {#s4}
==================

In this section, we use WFPGL to estimate the gene regulatory networks of type 2 diabetes patients and breast cancer patients, with 8,444 known gene interactions from TRRUST database ([@B22]) as prior network information and pathways collected from Kyoto Encyclopedia of Genes and Genomes (KEGG) database ([@B32]) as prior pathway information. The tuning parameters (λ~1~, λ~2~) are determined based on the following Akaike information criterion (AIC):
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where ${\hat{\Theta}}^{(k)}$ is the estimated precision matrix by using the tuning parameters λ~1~ and λ~2~, and $2n_{e}^{(k)}$ is the number of non-zero entities in ${\hat{\Theta}}^{(k)}$. We select the parameters λ~1~ and λ~2~, which obtain the outputs that minimize AIC(λ~1~, λ~2~) to generate the final estimation of Θ^(^ *^k^* ^)^.

Insulin Resistance in Type 2 Diabetes {#s4_1}
-------------------------------------

We downloaded the gene expression data of type 2 diabetes patients from ([@B16]), which contain 31 insulin-resistant (IR) samples and 31 insulin-sensitive (IS) samples. Four relevant pathways are used as prior pathway information, i.e., type 2 diabetes mellitus pathway, Wnt signaling pathway, AMPK signaling pathway, and PI3K--AKT signaling pathway. These four pathways are all implicated in type 2 diabetes. Wnt co-receptor (LRP-5) and the Wnt pathway effector TCF7L2 have been revealed in the development of diabetes ([@B29]). Targeted drugs have been designed to treat type 2 diabetes by activating AMPK signaling pathway ([@B30]) or PI3K--AKT signaling pathway ([@B27]).

We normalize each gene to have 0 mean and 1 standard deviation. By merging rows with the same gene name based on their average, 442 genes are covered by the prior pathway information. According to the experiences in simulation studies, we set *w* = 0.3 and choose λ~1~ (ranging from 0.05 to 0.5) and λ~2~ (ranging from 0.1 to 1) based on AIC. Networks for both IR and IS samples are built, and we calculate their difference to identify the network rewiring associated with insulin resistance.

For real data analysis, due to the lack of ground truth, it is hard to know whether the predicted regulatory relationships are real. As the changes of gene regulatory relationships are often derived by the aberrations of certain genes, we assess the performance of our method by quantifying how hub nodes in our estimated differential networks capture known functionally important genes. [**Table 1**](#T1){ref-type="table"} shows the top 10 hub genes in our predicted differential network between IR and IS patients. Among these genes, overexpression of MYC is verified to prevent insulin resistance ([@B45]); TP53 is found to be responsible for the formation of tissue-specific insulin resistance ([@B49]). In liver, inactivation of RELA leads to the improvement of insulin sensitivity ([@B33]); whole-body insulin sensitivity improves when VEGFA is overexpressed in adipose tissue ([@B17]); PRKAA2 gene interfering insulin resistance has been observed in the Japanese population ([@B24]). Although not confirmed, indirect evidence like statistics ([@B37]) or mouse experiments ([@B56]) indicate that EGFR and ITGA1 may be good candidates for insulin resistance. Besides, how RAC1 relates to insulin sensitivity after exercise has attracted a lot of attention ([@B35]).

###### 

Top 10 nodes with the highest degree in the predicted differential network between insulin-resistant (IR) and insulin-sensitive (IS) patients.

  Rank   1     2      3      4      5       6      7       8         9       10
  ------ ----- ------ ------ ------ ------- ------ ------- --------- ------- --------
  Name   MYC   TP53   RELA   EGFR   NFKB1   RAC1   VEGFA   CREB3L1   ITGA1   PRKAA2

Breast Cancer Subtypes {#s4_2}
----------------------

We consider the gene expression data from The Cancer Genome Atlas ([@B9]) that measure the expression levels of 17,327 genes in 511 patients with breast cancer. The observations are classified into four subtypes: 95 for basal-like, 58 for HER2 enriched, and 231 and 127 for luminal A and luminal B, respectively. In this study, we consider seven pathways, namely, apoptosis pathway, hedgehog signaling pathway, homologous recombination pathway, notch signaling pathway, TGF-5 signaling pathway, mTOR signaling pathway, and p53 signaling pathway, which cover 360 genes in the gene expression data. All these pathways are related to breast cancer. Strong evidence shows that reduced apoptosis will cause breast tumor growth, and high levels of apoptosis in a breast tumor are likely to predict worse survival ([@B42]). DNA repair pathways that targeted genes involved in homologous recombination were discovered to be associated with hereditary breast cancer, while almost 40% of familial and sporadic breast cancers are homologous recombination deficient ([@B14]). High notch1 expression was found to be associated with not only high-grade tumors but also poor prognosis for breast cancer ([@B60]). Changes in regulators of p53 activity were demonstrated to be predictive of early relapse in breast cancer ([@B18]). mTOR pathway is implicated in endocrine resistance in ER-positive tumors, and the targeted drugs may be used to treat brain metastases ([@B41]). Dysregulation of hedgehog and TGF-5 signaling pathway have been identified in the development and progression of breast cancer ([@B21]; [@B48]).

We build four state-specific networks corresponding to four breast cancer subtypes. We still set *w* = 0.3 but choose λ~1~ ranging from 0.01 to 0.1 and λ~2~ ranging from 0.001 to 0.01. [**Table 2**](#T2){ref-type="table"} shows the nodes with the highest degree in our inferred networks. Two types of genes are categorized by the fused penalty---cancer-related genes and subtype-specific genes.

###### 

Top 30 nodes with the highest degree in four breast cancer subtypes.

  Rank   Basal like   HER2 enriched   Luminal A   Luminal B
  ------ ------------ --------------- ----------- -----------
  1      IGF1         BMP4            PRKACB      BMP4
  2      TP53         IGF1            IGF1        IGF1
  3      TNF          ID4             BMP4        IFNG
  4      BCL2         IFNG            BMP2        FAS
  5      FAS          BCL2            TNF         RPS6KB2
  6      BMP2         BMP2            RPS6KB2     TP53
  7      THBS1        TP53            THBS1       PRKACB
  8      PIK3CG       BIRC3           FAS         BAMBI
  9      BMP4         RPS6KB1         TP53        THBS1
  10     IFNG         FAS             TGFB2       BMP2
  11     AKT3         BMPR1B          BIRC3       TNF
  12     BAMBI        MYC             BAMBI       PRKAR2B
  13     ID4          PIK3CG          BMPR1B      TNFRSF10B
  14     CDKN2B       RPS6KB2         RPS6KB1     BMPR1B
  15     TGFB2        TNF             AKT3        BMP7
  16     INHBB        BMP7            BCL2        ACVR1C
  17     RPS6KB2      THBS1           ACVR1C      IL1R1
  18     BIRC3        TGFB2           APAF1       BCL2
  19     PITX2        INHBB           AKT1        PIK3R1
  20     BMP7         DCN             ID4         ID4
  21     BMP5         AKT1            LEFTY1      APAF1
  22     LEFTY1       PRKACB          FST         BIRC3
  23     INHBA        BAMBI           PIK3R1      PITX2
  24     MYC          ACVR1C          IFNG        MYC
  25     CCNB3        LEFTY1          INHBB       PIK3CD
  26     PRKACB       CDKN2A          PRKAR2B     PMAIP1
  27     LEFTY2       SMAD9           PIK3CG      DCN
  28     BMP6         GADD45A         PIK3R5      AKT1
  29     PIK3CD       INHBA           INHBA       INHBB
  30     DCN          SERPINB5        PIK3R3      FASLG

The genes appeared in all subtypes are significantly associated with breast cancer. For example, IGF-1 gene is identified as a key player in major signaling pathways involved in breast cancer growth ([@B10]); TP53 gene mutations have been found in almost all subtypes ([@B6]); TNF gene is highly expressed in breast carcinomas, and its chronic expression supports tumor growth ([@B31]); BAMBI and interferon gamma protein (encoded by IFNG gene) are found to inhibit the tumor growth of breast cancer ([@B47]; [@B38]). In detecting breast cancer, experiments have revealed the diagnostic value of THBS1 protein ([@B50]). The overexpression and amplification of RPS6KB2 gene as well as FAS gene are reported to be associated with breast cancer prognosis ([@B44]; [@B4]); BMP2 is considered as a driving factor for promoting breast cancer stemness, and BMP4 is a potent suppressor of breast cancer metastasis ([@B26]; [@B1]).

In addition, the genes that emerged only in one subtype are regarded as potential subtype-specific genes, which may have diverse functions across subtypes. In this result, there are three subtype-specific hub genes identified by our method, i.e., CDKN2B in basal-like, and IL1R1 and TNFRSF10B in luminal B. CDKN2B protein is a cyclin-dependent kinase inhibitor that functions as a cell growth regulator, and its methylation is part of triple negative breast cancer (TNBC) profile ([@B8]). This result is also in accordance with a recent study ([@B3]) that declared that the copy number aberrations of CDKN2B gene suffer a high gain in basal-like 1 subtype. The high expression of IL-1a has been found to be correlated with better prognosis in luminal B breast cancer ([@B11]). Since IL1R1 protein is the receptor for IL-1α, there may be a latent relationship between the IL1R1 gene expression level and luminal B breast cancer. TNFRSF10B (also named as DR5) is a cell surface receptor that can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL) ([@B5]). TRAIL kills tumor cells while sparing normal cells and becomes a drug target. However, TRAIL may be selective to patients, since only a small subset of patients respond well to TRAIL in previous clinical trials ([@B15]). Considering that the lack of surface DR5 is sufficient to render tumors resistant to the targeted therapies ([@B53]), the correlation between DR5 and luminal B discovered by this paper could provide a new insight of TRAIL therapies on their receivers.

Conclusion {#s5}
==========

In this paper, we propose a novel weighted fused pathway graphical lasso (WFPGL) that can effectively incorporate additional knowledge including pathway information and gene interaction networks to jointly estimate multiple gene regulatory networks. These two kinds of prior information have different effects on our algorithm. We incorporate gene interaction priors by assigning a weight matrix to the estimated individual networks and differential networks. When there is no prior gene interaction information, all elements in the weight matrix are set to 1, and our model degenerates to a fused pathway graphical lasso model. For prior pathway information, we utilize the information by imposing constraints that a pair of genes can be connected to each other only if they co-occur in at least one pathway. The constraints have the potential of improving structure learning of gene regulatory networks. First, it can accelerate the optimization of the algorithm, leading to acceptable results when dealing with high-dimensional data. Second, making use of such prior information in learning the structures of networks can yield results that are more meaningful and interpretable. Moreover, as our algorithm is a flexible framework, the "pathway" here does not need to be an exact biological pathway. The "pathway" here stands for a partition of genes such that genes that belong to different "pathways" are less likely to have regulatory relationships. On the one hand, if we can collect additional information, such as the transcript factors (TFs) of genes in a given pathway, we could combine these TFs and their regulated genes into a new "pathway" such that the regulatory relationships are more likely to take place between genes within the same "pathways." On the other hand, if the pathway information is not comprehensive or remains unknown to us, we could treat all genes as a pathway, and our model degenerates to a weighted fused graphical lasso model.
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